Abbott Laboratories

3. Abbott Laboratories (before the spinoff into AbbVie)

Total Ad Spend: $301.7 million
Television: $264 million
Magazine: $35 million
Other: $2.7 million

Blockbuster Humira was the driving force behind Abbott Laboratories ($9.2 billion in sales in 2012) and now holds that distinction for AbbVie ($ABBV), the brand-new spinoff that took all of Abbott's ($ABT) pharma assets. Even the current top-selling drug worldwide can benefit from some advertising.

In the spotlight


Humira for arthritis, $84.5 million
AndroGel, $80 million
Humira for Crohn's disease, $57.2 million


 

Abbott Laboratories
Read more on

Suggested Articles

Fujifilm has completed the first manufacturing facility in Japan to make drug-delivering liposomes to use for cancer fighting drugs it is developing.

J&J chief Alex Gorsky has assured plenty of critics that its talc products are safe, but he's not interested in explaining to Congress.

That didn’t take long. Sanofi CEO Paul Hudson has only been at the reins for a couple months, but on Tuesday, he unveiled a major shakeup.